BehaveNet®
Clinical Capsule™

  
Join Our Mailing List

Email:

For Email Newsletters you can trust
Movies
 		Opinion
 Facebook
 Twitter

drug: lisdexamfetamine

Clinical class anorexiant, antinarcoleptic, psychostimulant (amphetamine-like)
Action sympathomimetic amine, central nervous system stimulant
Active metabolite (prodrug of) dextroamphetamine

 
Chemical class  
CSA schedule

II
DEA number

1205
NDC  
Routes of administration oral
Associated with (substance-related)  

 

 disorders
Availability prescription
MEDLINEplus® Drug Information
U.S. Preparations:

Vyvanse™ (Shire) FDA approved:
2.23.2007 for treatment of ADHD
US prescribing information

Dose: 30 mg. 50 mg. 70 mg.
Color:  white body - orange cap white body - blue cap blue body - orange cap
Type: capsule capsule capsule
Imprint: NRP 104 30 mg NRP 104 50 mg NRP 104 70 mg


http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2012 BehaveNet®
Privacy | Medica Network Privacy Statement